IDiyas

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Genocea Biosciences, Inc.


USPTO Granted Patents = 17



Trademarks = 2

Forward Citations = 51

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Jessica Baker Flechtner (12 out of 13 patents)

silverMedal Todd Michael Gierahn (9 out of 22 patents)

bronzeMedal Richard Malley (5 out of 27 patents)

4.  Deborah Long (5 out of 5 patents)

5.  Mojca Skoberne (5 out of 5 patents)

6.  George Rainer Siber (3 out of 26 patents)

7.  Marie Lossky-Elias (1 out of 1 patent)

8.  Pamela M Carroll (1 out of 1 patent)

9.  Hubert Lam (1 out of 1 patent)

10.  Lisa K McNeil (1 out of 1 patent)

11.  Wendy Jane Broom (1 out of 1 patent)

12.  Seth Vollmer Hetherington (1 out of 1 patent)

13.  Jessica Fletchner (0 patent)

14.  Jessica Flechtner (0 patent)

15.  Jessica Flechtner (0 patent)


17 patents:

1. 11207375 - Vaccines and compositions against (2021-12-28),
2. 11162093 - Antigen screening system (2021-11-02),
3. 10859566 - Treatment methods (2020-12-08),
4. 10653771 - Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response (2020-05-19),
5. 10570387 - Antigen screening system (2020-02-25),
6. 10350288 - Methods and compositions for treating herpes (2019-07-16),
7. 10188717 - [object Object] (2019-01-29),
8. 10105412 - [object Object] (2018-10-23),
9. 9895436 - Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response (2018-02-20),
10. 9873870 - Antigen screening system (2018-01-23),
11. 9782474 - Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response (2017-10-10),
12. 9765125 - [object Object] (2017-09-19),
13. 9624273 - Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response (2017-04-18),
14. 9393294 - [object Object] (2016-07-19),
15. 9045791 - Antigen screening system (2015-06-02),
Genocea Biosciences, Inc. is a biopharmaceutical company that discovers and develops novel vaccines and immunotherapies. The company focuses on using its proprietary ATLAS platform to develop personalized cancer immunotherapies and vaccines for infectious diseases. Genocea is committed to revolutionizing the treatment of numerous diseases by harnessing the power of the immune system.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

17 Patents

#129 in Cambridge, MA

#1,106 in Massachusetts

#18,300 in US

#34,819 in the World

...
Cambridge, MA, United States of America

Genocea Biosciences, Inc.

Forward Citations = 51

19 inventors:

goldMedal Jessica Baker Flechtner (12 out of 13 patents)

silverMedal Todd Michael Gierahn (9 out of 22 patents)

bronzeMedal Richard Malley (5 out of 27 patents)

4.  Deborah Long (5 out of 5 patents)

5.  Mojca Skoberne (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com
Loading…